Exelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue Guidance

Exelixis Inc. (NASDAQ:EXEL) reported adjusted net of 62 cents per stock connected Tuesday for the archetypal 4th of 2025, compared to 17 cents a twelvemonth ago, beating the statement of 36 cents.
The cancer-focused institution reported quarterly income of $555.45 million, beating the statement of…

This communicative appeared connected benzinga.com, 2025-05-14 14:44:27.